The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF)
Abstract
Background— Admission measures of renal function (blood urea nitrogen [BUN], estimated glomerular filtration rate [eGFR]) in patients hospitalized for worsening heart failure are predictors of in-hospital outcomes. Less is known about the changes and relationships among these variables and the postdischarge survival rate. Methods and Results— In a retrospective analysis of 949 patients from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure, we investigated the relation between admission values and changes in BUN and eGFR and rate of death by 60 days after discharge. On admission, median eGFR was 51 mL � min −1 � 1.73 m −2 (interquartile range, 37 to 70 mL � min −1 � 1.73 m −2 ), and BUN was 25 mg/dL (interquartile range, 17 to 41 mg/dL). On average, there was a 1.1–mL � min −1 � 1.73 m −2 decrease in eGFR and a 4.7-mg/dL increase in BUN from admission to discharge. By discharge, 12% of patients had a >25% decrease in eGFR, and 39% had a >25% increase in BUN. Although both lower admission eGFR and higher admission BUN were associated with higher risk of death by 60 days after discharge, multivariable-adjusted Cox proportional-hazards analysis showed that BUN was a stronger predictor of death by 60 days than was eGFR (χ 2 , 11.6 and 0.6 for BUN and eGFR, respectively). Independently of admission values, an increase of ≥10 mg/dL in BUN during hospitalization was associated with worse 60-day survival rate: BUN (per 5-mg/dL increase) had a hazard ratio of 1.08 (95% CI, 1.01 to 1.16). Although milrinone treatment led to a minor improvement in renal function by discharge, the 60-day death and readmission rates were similar between the milrinone and placebo groups. Conclusions— A substantial number of patients admitted with heart failure have worsening renal function during hospitalization. Higher admission BUN and increasing BUN during hospitalization, independently of admission values, are associated with a worse survival rate. Use of milrinone in these high-risk patients does not improve outcomes despite minor improvements in the renal function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Greene, T., Stevens, L. A., Zhang, Y. (., Hendriksen, S., Kusek, J. W., & Van Lente, F. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-4-200608150-00004 · Cited by 5,725
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Adams, K. F., Fonarow, G. C., Emerman, C. L., LeJemtel, T. H., Costanzo, M. R., Abraham, W. T., Berkowitz, R. L., Galvao, M., & Horton, D. P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.005 · Cited by 2,116
Self-citationFonarow, G. C. (2005) · JAMA · doi:10.1001/jama.293.5.572 · Cited by 1,611
Lee, D. S., Austin, P. C., Rouleau, J. L., Liu, P. P., Naimark, D., & Tu, J. V. (2003) · JAMA · doi:10.1001/jama.290.19.2581 · Cited by 1,272
Hormones and Hemodynamics in Heart Failure
Schrier, R. W., & Abraham, W. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410806 · Cited by 1,199
Cuffe, M. S. (2002) · JAMA · doi:10.1001/jama.287.12.1541 · Cited by 1,175
Renal Function, Neurohormonal Activation, and Survival in Patients With Chronic Heart Failure
Hillege, H. L., Girbes, A. R. J., de Kam, P. J., Boomsma, F., de Zeeuw, D., Charlesworth, A., Hampton, J. R., & van Veldhuisen, D. J. (2000) · Circulation · doi:10.1161/01.cir.102.2.203 · Cited by 1,045
Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure
Hillege, H. L., Nitsch, D., Pfeffer, M. A., Swedberg, K., McMurray, J. J. V., Yusuf, S., Granger, C. B., Michelson, E. L., Östergren, J., Cornel, J. H., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.580506 · Cited by 945
Forman, D. E., Butler, J., Wang, Y., Abraham, W. T., O'Connor, C. M., Gottlieb, S. S., Loh, E., Massie, B. M., Rich, M. W., Stevenson, L. W., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.07.031 · Cited by 912
Self-citation
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
Damman, K., Valente, M. A. E., Voors, A. A., O'Connor, C. M., van Veldhuisen, D. J., & Hillege, H. L. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht386 · Cited by 1,125
Self-citationGheorghiade, M., Follath, F., Ponikowski, P., Barsuk, J. H., Blair, J. E. A., Cleland, J. G., Dickstein, K., Drazner, M. H., Fonarow, G. C., Jaarsma, T., et al. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq045 · Cited by 739
Self-citationMetra, M., Davison, B., Bettari, L., Sun, H., Edwards, C., Lazzarini, V., Piovanelli, B., Carubelli, V., Bugatti, S., Lombardi, C., et al. (2012) · Circulation: Heart Failure · doi:10.1161/circheartfailure.111.963413 · Cited by 492
Cardiorenal Syndrome: New Perspectives
Bock, J. S., & Gottlieb, S. S. (2010) · Circulation · doi:10.1161/circulationaha.109.886473 · Cited by 455
Metadata
- Authors
- Klein, L., Massie, B. M., Leimberger, J. D., O’Connor, C. M., Piña, I. L., Adams, K. F., Califf, R. M., & Gheorghiade, M.
- Venue
- Circulation: Heart Failure
- Published
- 2008-05
- Volume
- 1
- Issue
- 1
- Pages
- 25-33
- ISSN
- 1941-3289 (ISSN-L)
- 1941-3297
- OpenAlex
- W2129212677
- Cited by
- 274
- References
- 37
- FWCI
- 14.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). https://app.cochat.ai/papers/10.1161/circheartfailure.107.746933
- The paper
- Klein, L., Massie, B. M., Leimberger, J. D., O’Connor, C. M., Piña, I. L., Adams, K. F., Califf, R. M., & Gheorghiade, M. (2008). Admission or Changes in Renal Function During Hospitalization for Worsening Heart Failure Predict Postdischarge Survival: Results From the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF). Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.107.746933
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.